IIM
CSTL icon

INTECH Investment Management’s Castle Biosciences CSTL Stock Holding History

INTECH Investment Management’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,718
Closed -$456K – 2156
2025
Q4 		$456K Sell
11,718
-674
-5% -$21.7K ﹤0.01% 1555
2025
Q3 		$282K Buy
12,392
+103
+0.8% +$2.09K ﹤0.01% 1859
2025
Q2 		$251K Sell
12,289
-3,789
-24% -$70.1K ﹤0.01% 1976
2025
Q1 		$322K Buy
16,078
+4,500
+39% +$111K ﹤0.01% 1849
2024
Q4 		$309K Buy
11,578
+3,294
+40% +$100K ﹤0.01% 1819
2024
Q3 		$236K Buy
+8,284
New +$211K ﹤0.01% 1643

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

INTECH Investment Management's CSTL Position: Q1 2026 in Review

INTECH Investment Management sold out of Castle Biosciences (CSTL) in Q1 2026, closing a stake of 11,718 shares — an estimated $456K sold.

INTECH Investment Management first reported a position in CSTL in Q3 2024 and held it in 6 quarters. The position peaked at $456K in Q4 2025. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • INTECH Investment Management reported no remaining Castle Biosciences position as of Q1 2026 after selling out during the quarter.
  • INTECH Investment Management sold 11,718 Castle Biosciences shares in Q1 2026, an estimated $456K.
  • INTECH Investment Management first reported a position in Castle Biosciences in Q3 2024 and held it in 6 quarters.
  • INTECH Investment Management's Castle Biosciences position peaked at $456K in Q4 2025.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.